Open-pored, dimensionally stable, flame retardant, lightweight board

03.07.2019Published 16 days ago
Technology
TRCH20190703001
Requests
A Swiss company is looking for a board manufacturer - or a research & development partner - that produces - or develops - an open-pore, air-permeable, non-flammable or flame retardant, lightweight board. The board size is approximately 3.0 m x 1.2 m. The semi-finished product can be delivered from anywhere in the world and will be finished, processed and distributed by the Swiss company.

Bespoke Direct Current Current Transducers (DCCTs) required for the largest particle physics accelerator in the world

27.06.2019Published 22 days ago
Technology
TRCH20190626001
Requests
A DCCT is a high-precision transducer based on the zero-flux detection principle. The current to be measured (primary current) is passed through the centre of a toroidal core (transducer head). The output of a zero flux detector is used in a current control loop to generate a compensation current (secondary current) which is an accurate fraction of the primary current according to the primary-secondary turns ratio.

Novel drugs for the treatment of aging-related diseases like chronic wounds, glaucoma, skin fibrosis and skin-aging.

25.06.2019Published 24 days ago
Technology
TOCH20190625001
Offers
Diabetes mellitus is one of the major health concerns worldwide affecting 425 million people and its prevalence is expected to increase to 629 million in 2045. It is estimated that 12% of the global health expenditure is spent on diabetes (around $727 billion). One serious complication of diabetes mellitus is the diabetic foot ulcer (DFU). Impaired local blood circulation and the resulting low tissue oxygenation, nutrient supply and waste elimination is a major cause for compromised wound healing in diabetic patients and wounds often become chronic and non-healing.

Simple low-loss power converter allowing great energy savings.

05.06.2019Published 44 days ago
Technology
TOCH20190605001
Offers
An established research institute of a Swiss university of applied sciences has invented a new topology for highly efficient switched mode power converters with low electromagnetic interferences (EMI). Along with the right method of control, this topology allows to reduce the power losses by approximately 50% compared to conventional switched mode power converters, which allows very high energy savings. Thus, conversion efficiency of 99% or more can be achieved. Despite the superior performance, the topology is simple and easy to drive.

A Swiss manufacturer of cough relief suppositories for babies and infants is looking for a distribution partner agreement

26.11.2018Published 235 days ago
Commercial
BOCH20180815001
Offers
The Swiss young SME was established in 2014 and has been founded by two entrepreneurs focused on the development of innovative health products for niche markets. With a strong background in pharmacology and economics, they have ongoing analysis of the markets and seize opportunities to develop new innovative plants based medicines to fill gaps in the market. The suppository, based on a fine selection of plants extracts, is specifically formulated for babies and infants. It effectively suppresses a cough after 2 to 3 administrations and has no known side effects.

Looking for a manufacturer of tungsten shielding elements.

16.11.2018Published 245 days ago
Technology
TRCH20181116002
Requests
The accelerator currently used by the Swiss NGO is installed in a 27 km circumference tunnel, about 100 m underground. Its design is based on superconducting twin-aperture cryo-magnets which operate in a superfluid helium bath at 1.9 K. A project is running with the aim to upgrade the collider after 2020-2025 in order to maintain scientific progress and exploit its full capacity. By increasing its peak luminosity by a factor five over nominal value it will be able to reach a higher level of integrated luminosity, nearly ten times the initial design target.

Looking for manufacturer of metal bellows expansion joints

16.11.2018Published 245 days ago
Technology
TRCH20181116001
Requests
The Swiss NGO & research centre intends to place a contract (manufacturing agreement) for the supply of 600 metal bellows expansion joints. The metal bellows expansion joints will be used to connect the hydraulic circuits of superconducting magnets and will provide flexibility for installation and thermal contractions. The operating temperature spreads from 1.9 K (–272.15 °C) to ambient temperature, and the internal operating pressure from vacuum to 20 bar.

Manufacturing of an implantable neurological electrode

14.11.2018Published 247 days ago
Technology
TRCH20180917001
Requests
An internationally awarded Swiss medical technology start-up company is developing a neuroprosthetic device. The prostheses equipped with the neuroprosthetic device allow amputees to feel again from missing limbs. The device will be implanted within the residual or healthy part of the nerves and restore the flow of the neural sensory information. The SME is seeking an original equipment manufacturer (OEM) able to produce implantable neural electrodes in a certified environment (compliant with ISO standards for implantable medical devices).

Zero-power receiver for touch communication and touch sensing

31.10.2018Published 261 days ago
Technology
TOCH20181029001
Offers
Background: As more and more smart devices enter the market, communication with and between smart devices becomes more relevant and advanced. A typical means of communication between smart devices is radiofrequency (Bluetooth or RFID (Radio-Frequency IDentification)). The transmission of radio signals requires energy. For battery powered smart devices, energy is a limited resource and the energy household has to be carefully managed, for example by switching to the stand-by mode when not in use.

Technology for reliable drug targeting to the colon

30.10.2018Published 262 days ago
Technology
TOCH20181030001
Offers
Efficient and reliable delivery of drugs to the colon has not been achieved so far, although urgently required for the treatment of inflammatory bowel disease, a malady with increasing incidence. The difficulty in consistent colonic delivery is caused by the individual and circumstantial variability of the human digestive tract (pH, residence time, water content, food intake, volume, peristaltic movement, etc.). Scientists at a Swiss university of applied sciences have developed a novel technology for colonic drug delivery by per-oral administration.

Stránky